Free Trial

Chemomab Therapeutics (CMMB) Institutional Ownership

Chemomab Therapeutics logo
$1.71 -0.06 (-3.39%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.70 -0.01 (-0.58%)
As of 02/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)

Current
Institutional Ownership
Percentage
46.05%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$1.95M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$118.72K
Get CMMB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CMMB Institutional Buying and Selling by Quarter

Chemomab Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/13/2025 XTX Topco Ltd24,929$45K0.0%+63.8%0.174%
2/11/2025 Virtu Financial LLC14,445$26K0.0%N/A0.101%
2/5/2025 Yelin Lapidot Holdings Management Ltd.744,127$1.35M0.2%-8.1%5.182%
11/15/2024 Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458%
2/1/2023 Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271%
2/14/2022 GSA Capital Partners LLP11,277$78K0.0%N/A0.099%
1/28/2022 ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344%
11/17/2021 Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027%
11/5/2021 Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481%
11/3/2021 Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330%
9/17/2021 Virtu Financial LLC13,180$251K0.0%N/A0.116%
8/25/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.558%
8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386%
8/18/2021 Ikarian Capital LLC290,534$5.53M0.4%N/A2.640%
8/18/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370%
8/17/2021 Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512%
8/16/2021 Marshall Wace LLP63,554$1.21M0.0%N/A0.594%
8/5/2021 Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380%
5/18/2021 Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320%
5/13/2021 Renaissance Technologies LLC7,023$202K0.0%N/A0.301%
5/6/2021 Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356%
(Data available from 1/1/2016 forward)

CMMB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CMMB shares?

During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Yelin Lapidot Holdings Management Ltd. ($1.35M), and XTX Topco Ltd ($45K), Virtu Financial LLC ($26K).Learn more on CMMB's institutional investors.

What percentage of Chemomab Therapeutics stock is owned by institutional investors?

46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings.

Which institutional investors have been buying Chemomab Therapeutics stock?

The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), Virtu Financial LLC ($14.45K), and XTX Topco Ltd ($9.71K).

How much institutional buying is happening at Chemomab Therapeutics?

Institutional investors have bought a total of 1,238,726 shares in the last 24 months. This purchase volume represents approximately $1.95M in transactions.

Which Chemomab Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Chemomab Therapeutics stock in the last 24 months: Yelin Lapidot Holdings Management Ltd. ($65.59K).

How much institutional selling is happening at Chemomab Therapeutics?

Institutional investors have sold a total of 65,590 shares in the last 24 months. This volume of shares sold represents approximately $118.72K in transactions.



This page (NASDAQ:CMMB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners